首页 | 本学科首页   官方微博 | 高级检索  
     


TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer
Authors:Nicholas D James  Wenyu Liu  Sarah Pirrie  Baljit Kaur  Carey Hendron  Daniel Ford  Anjali Zarkar  Richard Viney  Elizabeth Southgate  Amisha Desai  Syed A Hussain  the TUXEDO investigators
Affiliation:1. Institute of Cancer Research, London, UK;2. Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK;3. Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;4. Department of Oncology & Metabolism, The Medical School, Sheffield, UK;5. Additional investigators of the TUXEDO trial are listed in Appendix  S1, available online.
Abstract:
Keywords:muscle-invasive bladder cancer  cetuximab  clinical trial  chemoradiotherapy  feasibility  #BladderCancer  #blcsm  #uroonc
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号